Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001213900-25-072867·ALPHA CAPITAL ANSTALT
Schedule 13G ownership disclosure
Qualigen Therapeutics, Inc.
COMMON STOCK, $0.001 PAR VALUE PER SHARE · CUSIP: 74754R103
Event date: 2025-07-21
- Filing-level shares
- 36,434.00
- Percent of class
- 2.223%
- Alpha Capital Anstalt
Shares: 36,434.00 · Class: 2.223%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-072867
- Form type
- SCHEDULE 13G/A
- Filer
- ALPHA CAPITAL ANSTALT
- CIK
- CIK 1140358
- Filed
- Aug 07, 2025
- Reporting period
- Jul 21, 2025
- Description
- Schedule 13G beneficial ownership